$NHI

MCCABE ROBERT A JR purchased $64K of NHI

MCCABE ROBERT A JR purchased 890 shares of NATIONAL HEALTH INVESTORS INC (NHI) at $71.65 on 2026-06-15.

Original reporting
SEC EDGAR · MCCABE ROBERT A JR
Published Jun 15, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 10:57 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NHI
Neutral
medium confidence
Mentioned
$NHI
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NHINeutralLow
01

Why it matters

The only new information is the director’s open-market purchase details (shares, price, total value, and post-transaction holdings).

02

Market read

Traders may note the insider buy as a small sentiment input, but there is no fundamental update (earnings, guidance, deal, or regulation) in the article.

03

What to watch

The filing states no pre-arranged 10b5-1 plan, but it still does not disclose the director’s rationale, timing constraints, or whether the buy is part of a broader pattern.

Relevance 4/10Novelty 3/10Timing: filed 2026-06-15 (same day as transaction)

Background

This is an SEC Form 4 insider transaction disclosure for National Health Investors Inc.

Company-level read

Ticker impact

$NHINeutralMedium confidence
Context

National Health Investors disclosed an insider open-market purchase by director Robert A. McCabe Jr. of 890 shares at $71.6485 on 2026-06-15.

Expected impact

Likely limited near-term impact; any effect is sentiment-only unless followed by additional disclosures.

Evidence & confidence

Form 4 insider buys can be informative, but this is a single, modest transaction size with no accompanying guidance, deal, or regulatory action in the text.

Market effects

No sector-wide read-through is provided beyond a single REIT insider transaction.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine (compensation, diversification, or pre-planned liquidity needs) and may not reflect a new view on fundamentals.

Key entities

  • NATIONAL HEALTH INVESTORS INC

    Subject of the Form 4 insider transaction disclosure.

  • MCCABE ROBERT A JR

    Director who purchased 890 shares on 2026-06-15 at $71.6485/share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NHIHighAI 8/10

NHI (NHI) Q2 2026 Earnings Call Transcript

NHI reported Q2 2026 earnings with net income per share up 45.6% to $1.15, driven by real estate sales. NAREIT FFO per share remained flat at $1.19, while normalized FFO per share decreased 2.5% due to transition costs. The company completed a $560M portfolio sale, increasing liquidity and reducing leverage. NHI plans to expand its senior housing operating portfolio (SHOP) to 40-50% of its total portfolio within three years, with $127.3M in new investments under signed letters of intent. The qua

$NHIMed

National Health Investors, Inc. Q2 2026 Earnings Call Summary

National Health Investors (NHI) reported Q2 2026 updates, including completion of the NHC portfolio sale on July 1 and plans to redeploy $334 million via Section 1031 exchanges. It said SHOP investment rose 137% to about $850 million and targets 40% to 50% of total NOI over three years. Management guided for 8% to 9% same-store SHOP NOI growth in 2H.

$NHIMed

NHI accelerates senior living pivot with completion of SNF-focused portfolio sale

National Health Investors (NHI) said it completed the sale of its National HealthCare Corp. portfolio of 32 skilled nursing facilities and three independent living communities, as part of a shift toward private-pay senior housing. NHI reported $273.2M YTD investments, including $212.0M in SHOP, and aims for SHOP to reach 40%-50% of its portfolio. It also hired a new COO and reported SHOP NOI up 188.5% YoY.

$NHIMed

National Health Investors Q2 Earnings Call Highlights

National Health Investors (NYSE:NHI) reported Q2 results with normalized FFO per share down 2.5% to $1.19 and funds available for distribution up 5.8% to $61.6 million. The board raised its quarterly dividend to $0.94 per share. NHI completed a $560 million sale of its NHC portfolio, expecting about a $541.6 million gain in Q3 and using proceeds for replacement properties and Section 1031 reinvestment.

$NHIMed

National Health Investors: Q2 Earnings Snapshot

National Health Investors Inc. (NHI) reported Q2 funds from operations of $57.8 million, or $1.19 per share, and net income of $55.6 million, or $1.15 per share, with revenue of $121.3 million. The REIT expects full-year funds from operations of $4.74 to $4.79 per share, according to the company.